A method for preparing and applying high-throughput organoid microspheres
By forming a hydrogel precursor enrichment layer on the cell surface and resuspending the cells in a low-viscosity resuspension solution, the coupling problem between cell density and rheological properties in organoid microsphere preparation was solved, enabling the efficient construction of ultra-high cell density organoid microspheres and accurate reproduction of the physiological microenvironment. This method is applicable to various high-throughput model construction techniques.
Patent Information
- Application Number
- CN202611296826.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-25
- Publication Date
- 2026-11-10
AI Technical Summary
Existing organoid microsphere preparation technologies cannot effectively decouple the strong binding relationship between cell density and system rheological properties, resulting in difficulties in preparing high-density organoid microspheres and insufficient ability to reproduce physiological microenvironments.
A hydrogel precursor material is used to form an enrichment layer on the cell surface. The cells are then resuspended in a low-viscosity resuspension solution to form a bio-ink and trigger a cross-linking reaction, thereby constructing ultra-high cell density organoid microspheres and decoupling cell density from the rheological properties of the system.
While ensuring high-throughput processing performance, ultra-high cell density organoid microspheres were constructed, which can accurately reproduce the physiological microenvironment of real tissues, improve the preparation speed and consistency of organoid models, and are applicable to a variety of high-throughput model construction technologies.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] This invention relates to the fields of biomanufacturing and tissue engineering technology, and in particular to a method for preparing and applying high-throughput organoid microspheres. Background Technology
[0002] In the fields of organoid culture and high-throughput drug screening, constructing three-dimensional models that can realistically reproduce the in vivo tissue microenvironment is crucial. Current organoid microsphere preparation techniques typically involve directly and uniformly mixing cells in a hydrogel precursor solution, followed by physical or chemical cross-linking to form gel microspheres. However, this traditional construction logic has significant technical bottlenecks: on the one hand, to maintain the integrity of the gel structure, the system must contain a sufficient amount of hydrogel precursor material. This causes the macroscopic viscosity of the resulting bioink to increase sharply with increasing cell density, making it difficult to uniformly disperse cells under high cell density conditions. Furthermore, it easily leads to nozzle clogging or unstable droplet formation during 3D bioprinting or microfluidic molding. On the other hand, the high viscosity of the gel system limits cell migration and self-assembly capabilities, and excessive extracellular matrix material often hinders the exchange efficiency of nutrients and metabolites.
[0003] In related technologies, to address the aforementioned issues, some researchers have attempted to introduce dynamic hydrogels or optimize printing processes to improve the culture of large-volume organoids. However, these approaches essentially remain within the traditional paradigm of "cells suspended in a continuous gel phase," failing to fundamentally decouple the strong binding relationship between cell density and the system's rheological properties. This makes it difficult to achieve ultra-high cell densities (e.g., ≥5×10⁻⁶) close to those of real tissues while maintaining high-throughput processing performance. 7 The precise reproduction of physiological microenvironments such as membrane surface contact and paracrine communication (cells / mL) and corresponding membrane surface contact and paracrine communication.
[0004] Therefore, developing a novel preparation strategy that can achieve the construction of ultra-high cell density organoid microspheres while ensuring high-throughput processing performance has extremely important application value. Summary of the Invention
[0005] This invention aims to address at least one of the technical problems existing in the prior art. To this end, this invention proposes a method for preparing and applying high-throughput organoid microspheres, aiming to solve the problem that current organoid construction schemes cannot fundamentally decouple the strong binding relationship between cell density and system rheological properties, and that the strong coupling between cell density and system macroscopic viscosity leads to difficulties in preparing high-density organoid microspheres and insufficient ability to reproduce physiological microenvironments. This invention proposes a method for preparing high-throughput organoid microspheres, which decouples cell density from the rheological properties of the system, thereby constructing ultra-high cell density organoid microspheres with real tissue characteristics while ensuring high-throughput processing performance.
[0006] The present invention also provides applications of the above preparation method.
[0007] This invention also provides a bio-ink for preparing organoid microspheres.
[0008] According to an embodiment of the first aspect of the present invention, a method for preparing organoid microspheres is provided, comprising the steps of: S100. Cells are incubated using a hydrogel precursor material to form a hydrogel precursor enrichment layer on the surface of the cells. S200. Cells with the hydrogel precursor enrichment layer on their surface are resuspended using a low-viscosity resuspension solution to obtain bio-ink. S300: The bio-ink is shaped into microspheres, and a cross-linking reaction is triggered in the hydrogel precursor enrichment layer to obtain the organoid microspheres.
[0009] This invention fundamentally decouples the strong binding relationship between cell density and the macroscopic viscosity of the system by changing the formation mechanism of the gel network from the traditional "intercellular free gel crosslinking" to "local crosslinking between cell surface enrichment layers." Compared with current gel culture systems, this invention significantly increases the maximum formable cell density of organoid models, enabling the reproduction of cell / organoid membrane surface contact, paracrine communication behaviors, and physiological environments such as hypoxia, more closely resembling real tissue conditions. Higher cell density also facilitates organoid self-assembly processes, eliminating the need to consider the uncontrollability caused by incomplete digestion. Furthermore, the ultra-high cell density satisfies various high-throughput model construction technologies while allowing for negligible cell sedimentation, avoiding problems such as uneven cell density that arise during complex 3D bioprinting. Moreover, compared to suspension culture systems, this invention still incorporates a hydrogel environment mimicking the extracellular matrix, more closely resembling real human tissue. Simultaneously, cell aggregation is no longer completely random but is pre-determined during preparation, resulting in more consistent cultures.
[0010] In some embodiments of the present invention, the concentration of the hydrogel precursor material in the low-viscosity resuspension is below the threshold for forming a macroscopic gel network.
[0011] In this invention, because the concentration of hydrogel precursor in the resuspension is lower than the threshold for forming a macroscopic gel network, the system maintains low viscosity fluid properties on a macroscopic level, enabling ultra-high density cells to be uniformly dispersed and smoothly pass through microfluidic chips or printing nozzles, avoiding clogging and sedimentation problems caused by high viscosity. At the microscopic level, the enrichment layer on the cell surface forms an extracellular matrix-like microenvironment in situ after triggering cross-linking, ensuring the three-dimensional support and biochemical signals required for organoid growth.
[0012] In some embodiments of the present invention, the cell density in the bio-ink is ≥5×10⁻⁶. 7 Cells / mL. The upper limit of cell density set by this invention breaks through the physical limits of traditional gel culture, enabling the intercellular spacing inside the constructed microspheres to reach the level of real tissue, which is conducive to the establishment of direct intercellular communication.
[0013] In some embodiments of the present invention, the cell density in the bio-ink is 5 × 10⁻⁶. 8 Cells / mL ~5×10 9 Cells / mL. For example, it could be 5 × 10⁻⁶. 8 cells / mL, 1×10 9 cells / mL, 2×10 9 cells / mL, 3×10 9 cells / mL, 4×10 9 cells / mL, 5×10 9 Cells / mL, or within the range of any two of the above values. This invention utilizes ultra-high cell density (5 × 10⁻⁶ cells / mL). 8 Cells / mL ~5×10 9 The cell / organoid culture system (5 × 10⁻⁶ cells / mL) is used to reproduce cell / organoid communication behaviors such as membrane surface contact and paracrine secretion, as well as physiological environments such as hypoxia. This invention defines an ultra-high cell density range (5 × 10⁻⁶ cells / mL). 8 Cells / mL ~5×10 9 The density of cells per mL is its core indicator that distinguishes it from other schemes. At this density, the cell sedimentation effect is greatly suppressed, and hypoxia gradients and paracrine factor enrichment areas can be spontaneously formed inside the microspheres, which highly simulates the pathophysiological characteristics of tissues such as solid tumors.
[0014] In some embodiments of the present invention, the hydrogel precursor material has cell surface affinity. The present invention uses a hydrogel precursor material with strong interaction with cells to incubate cells / organoids, forming a material-rich layer on the cell surface.
[0015] In some embodiments of the present invention, the hydrogel precursor material interacts with the surface of the cell through electrostatic adsorption, hydrogen bonding or specific molecular binding to form the hydrogel precursor enrichment layer.
[0016] Specifically, the specific molecular binding includes specific donor-acceptor binding, but is not limited to this; it is acceptable as long as there is a specific group that can specifically bind.
[0017] This invention utilizes the specific or non-specific interactions between the material and the cell surface to ensure that the hydrogel precursor material can be stably and uniformly anchored on the cell surface, preventing it from falling off during subsequent resuspension and washing in low-viscosity solutions. This ensures that each cell unit has independent gelation potential, laying the material basis for the subsequent construction of uniform high-density microspheres.
[0018] In some embodiments of the present invention, the hydrogel precursor material includes at least one of natural polymer materials, modified natural polymer materials, or synthetic polymer materials, but is not limited thereto.
[0019] In some embodiments of the present invention, the hydrogel precursor material includes at least one of Matrigel, Type I collagen, fibrin, methacrylamide collagen (ColMA), methacrylamide gelatin (GelMA), methacrylamide hyaluronic acid (HAMA), or methacrylamide chitosan (CSMA), but is not limited thereto.
[0020] This invention provides a variety of validated biocompatible material options, using hydrogel precursor materials that have strong interactions with cell surfaces (such as matrix gel, type I collagen, fibrin, methacrylamide collagen ColMA, methacrylamide gelatin GelMA, methacrylamide hyaluronic acid HAMA, methacrylamide chitosan CSMA, etc.). The selected materials are all major components of the extracellular matrix or their photosensitive modified derivatives, and can provide suitable cell adhesion and proliferation signals.
[0021] In some embodiments of the present invention, the preparation method includes at least one of the following: (a1) Prepare a precursor solution of the hydrogel precursor material with a mass-volume concentration of 0.5% to 50%, and incubate the cells with it; (a2) The incubation time is 2 to 30 minutes; (a3) The low-viscosity resuspension includes at least one of a buffer solution or a cell culture medium; (a4) The low-viscosity resuspension also contains a cross-linking triggering agent, which is used to trigger the cross-linking reaction of the hydrogel precursor enrichment layer; (a5) The low-viscosity resuspension also contains a cross-linking trigger, which includes at least one of a photoinitiator, thrombin, or calcium ions; (a6) The cells are in a single-cell state or incompletely digested cell clumps; (a7) The source of the cells includes patient-derived tumor organoids, tumor cell lines or primary cells.
[0022] In some embodiments of the present invention, in step S100, the hydrogel precursor material is prepared as a precursor solution with a concentration of 0.5% to 50% (w / v) and the cells are incubated. Exemplarily, the concentration can be 0.5% (w / v), 1.0% (w / v), 5% (w / v), 10% (w / v), 15% (w / v), 20% (w / v), 25% (w / v), 30% (w / v), 35% (w / v), 40% (w / v), 45% (w / v), 50% (w / v), or within any range of two of the above values. Preferably, it is 2% to 30% (w / v).
[0023] In some embodiments of the present invention, the hydrogel precursor material is methacrylamide gelatin (GelMA), and the methacrylamide gelatin is prepared into a precursor solution with a concentration of 5% to 30% (w / v) and the cells are incubated.
[0024] In some embodiments of the present invention, the hydrogel precursor material is methacrylamide hyaluronic acid (HAMA), and the methacrylamide hyaluronic acid is prepared into a precursor solution with a concentration of 2% to 10% (w / v) and the cells are incubated.
[0025] In some embodiments of the present invention, in step S100, the incubation time is 2 to 30 minutes. For example, it can be 2 minutes, 5 minutes, 10 minutes, 15 minutes, 20 minutes, 25 minutes, 30 minutes, or within any two of the above values.
[0026] This invention optimizes the process window by combining a specific concentration range with an incubation time. This ensures that the thickness of the cell surface enrichment layer is sufficient to support subsequent cross-linking and gelation, while avoiding decreased cell activity or obstructed nutrient transport due to excessive material coating.
[0027] In some embodiments of the present invention, the low-viscosity resuspension includes at least one of a buffer solution or a cell culture medium, but is not limited thereto.
[0028] This invention uses incubated cells / organoids to be resuspended in a very small amount of solution of anhydrous gel precursor material. The subsequent culture model is constructed through cross-linking between the enrichment layer materials. Resuspending cells in a low-viscosity solution of the anhydrous gel precursor material avoids the difficulties in cell dispersion and uneven material distribution at ultra-high cell densities encountered in traditional methods, significantly increasing the maximum achievable cell density (≥5×10⁻⁶). 8(cells / mL). This invention clarifies the key parameter boundaries for achieving high-throughput, high-density preparation, and uses buffer / culture medium containing little or no gel precursor as the resuspension medium, ensuring that the system maintains Newtonian or near-Newtonian fluid behavior even at extremely high cell loads.
[0029] In some embodiments of the present invention, the low-viscosity resuspension further comprises a crosslinking trigger, which is used to trigger a crosslinking reaction in the hydrogel precursor enrichment layer. The present invention integrates the "pre-mixed and used" and "instant crosslinking" processes by pre-mixing the crosslinking trigger in the low-viscosity resuspension, avoiding the disturbance to the stability of the high-density cell suspension caused by additional addition steps.
[0030] In some embodiments of the present invention, the crosslinking trigger includes at least one of a photoinitiator, thrombin, or calcium ions, but is not limited thereto. In the present invention, if the gelation transition process of the gel system requires the cooperation of other substances (e.g., photoinitiator for photocrosslinked hydrogels, thrombin and calcium ions for fibrin gels), the corresponding substances are added to a low-viscosity resuspension (e.g., PBS buffer) to prepare a commonly used concentration of cell resuspension solution; if not, the low-viscosity resuspension solution (e.g., PBS buffer) is used directly as the cell resuspension solution.
[0031] In some embodiments of the present invention, the cells are in a single-cell state or incompletely digested cell clumps. In the present invention, whether they are single cells or clumps with some cell connections remaining, they can be effectively encapsulated and fixed through a surface enrichment mechanism.
[0032] In some embodiments of the present invention, the source of the cells includes, but is not limited to, patient-derived tumor organoids, tumor cell lines, or primary cells.
[0033] Tumor organoids are a class of organoid models with significant translational value, the most representative being patient-derived tumor organoids (PDOs). PDO models involve isolating cells from patient tumor tissue and culturing them in a three-dimensional culture system containing multiple growth factors, allowing them to self-assemble into miniature tumor structures. Compared to traditional two-dimensional cell lines, PDO models can maximally preserve the genetic heterogeneity, histological characteristics, and drug response properties of the primary tumor, overcoming the limitations of animal models such as long cycles and species differences. Currently, this model is widely used in tumor mechanism research, high-throughput drug screening, and is a core tool guiding personalized precision clinical treatment, serving as a crucial bridge connecting basic and clinical translation. This invention's support for cell sources, particularly patient-derived tumor organoids (PDOs), allows this method to be directly applied to in vitro amplification and drug sensitivity testing of clinical samples, preserving the heterogeneous characteristics of the primary tumor, expanding its biological applicability, and possessing significant translational medical value.
[0034] In some embodiments of the present invention, the bio-ink is formed into the microspheres by 3D bioprinting, droplet microfluidics, or manual dotting.
[0035] In some embodiments of the present invention, the droplet microfluidics employ a microfluidic chip. Specifically, a schematic diagram of one type of microfluidic chip is shown below. Figure 1 As shown in the figure, the bio-ink is connected to the aqueous phase inlet of the microfluidic chip, and HFE-7200 electronic fluorinated liquid is simultaneously introduced into the oil phase inlet. This allows the ultra-high cell density bio-ink to be sheared into microdroplets by the fluorinated liquid in the microfluidic chip, and then formed into microspheres in the middle section of the outlet pipe under 405 nm light.
[0036] The preparation method of this invention has broad compatibility with mainstream high-throughput manufacturing platforms and is suitable for various applications, including 3D bioprinting, droplet microfluidic microsphere preparation, and manual plate-forming techniques, without the cell sedimentation problem common in these technologies. Thanks to the unique low-viscosity rheological properties of bio-inks, this invention eliminates the need for complex flow channel modifications or pressure compensation for specific equipment. It enables high-speed jetting in 3D bioprinting, monodisperse droplet generation in microfluidics, and rapid spotting in manual operations, significantly improving the throughput and standardization of organoid model preparation, achieving a model preparation speed of ≥1000 models / min.
[0037] In some embodiments of the present invention, triggering a crosslinking reaction in the hydrogel precursor enrichment layer includes at least one of the following methods: When the hydrogel precursor material is a photosensitive material, the microspheres are irradiated with a light source of a specific wavelength to induce photopolymerization and crosslinking. When the hydrogel precursor material is fibrin, enzymatic cross-linking is triggered by thrombin and calcium ions contained in the low-viscosity resuspension. When the hydrogel precursor material is an ion-sensitive material, the microspheres are introduced into a crosslinking bath containing divalent cations for ion crosslinking.
[0038] This invention provides diverse crosslinking triggering strategies for different material systems, enhancing the versatility and flexibility of the technology. In particular, for photocrosslinking systems, due to the high local concentration of photosensitive groups within the enriched layer, rapid and efficient site-specific curing can be achieved even with low photoinitiator concentrations in the external solution, reducing cell damage from light dose. For enzymatic or ionic crosslinking systems, the rapid diffusion characteristics of the trigger in low-viscosity media are utilized to ensure the uniformity of crosslinking levels inside and outside the microspheres.
[0039] In some specific embodiments of the present invention, the method for preparing the organoid microspheres includes the following steps: (1) A gel precursor solution with a concentration of 0.5-25% (w / v) was prepared using hydrogel precursor materials that have strong interaction with the cell surface (such as matrix gel, type I collagen, fibrin, methacrylamide collagen ColMA, methacrylamide gelatin GelMA, methacrylamide hyaluronic acid HAMA, methacrylamide chitosan CSMA, etc.); (2) If the gelation process of the gel system requires the cooperation of other substances (such as photoinitiator for photocrosslinked hydrogel, thrombin and calcium ions for fibrin gel), the corresponding substances are added to the PBS buffer to prepare a cell resuspension solution of commonly used concentration; otherwise, the PBS buffer is used directly as the cell resuspension solution. (3) Digest cells / organoids into single-cell states and count the cells; (4) Resuspend the digested single cells in gel precursor solution to achieve a cell density ≤1×10⁻⁶. 8 Cells / mL, incubate the cell suspension at room temperature or 37°C for 2-30 minutes with static or slow shaking, and remove the supernatant by centrifugation; (5) Based on the required cell density (5×10⁻⁶) 8 Cells / mL ~5×10 9 By adding a certain amount of the corresponding cell resuspension solution to the cell pellet (cells / mL), ultra-high cell density bio-ink can be obtained and used for organoid microsphere construction; (6) The bio-ink is molded into microspheres and the cross-linking reaction of the hydrogel precursor material is triggered to obtain organoid microspheres.
[0040] This invention utilizes the strong interaction between hydrogel precursor materials and cell surfaces to form a material enrichment layer on the cell surface. Through cross-linking between materials in this enrichment layer, ultra-high cell density models are constructed. By constructing ultra-high cell density cell / organoid culture systems, the communication behaviors of cells / organoids, such as membrane surface contact and paracrine signaling, as well as physiological environments such as hypoxia, can be reproduced. The resulting ultra-high cell density bio-ink can be directly applied to various mainstream 3D model preparation methods, including conventional manual plate making, 3D bioprinting, and droplet microfluidic microsphere fabrication. Its application method is completely consistent with that of conventional cell-borne photocrosslinked bio-inks. Using 3D bioprinting technology for ultra-high cell density organoid microsphere fabrication, a model fabrication speed of ≥1000 microspheres / min can be achieved.
[0041] According to an embodiment of the second aspect of the present invention, an application of the above-described method for preparing organoid microspheres is provided in the fields of high-throughput organoid culture or high-throughput drug screening.
[0042] Traditional organoid culture methods mainly include suspension culture and gel culture. Among them, hydrogel-based culture methods (such as Matrix) can, to a certain extent, replicate the extracellular matrix environment of real tissues, making them suitable for more types of organoid culture. Based on hydrogel-based culture methods, various organoid culture models have been developed, including handmade gel dropper plates, 3D bioprinting, and gel microspheres based on microfluidic chips. Organoid microsphere models, in particular, have unique advantages in high-throughput drug evaluation and other fields due to their large specific surface area that facilitates material exchange and their smaller individual model volume. However, current organoid culture technology still faces some significant challenges: on the one hand, organoid formation is highly dependent on cell autoassembly; however, traditional three-dimensional culture methods based on gel systems often require only a certain amount of cells to be dispersed sporadically into gel environments such as Matrix to maintain culture stability. Organoid formation relies on long-distance cell migration and cell proliferation, leading to significant differences in organoid formation rates among different cell types and origins. One alternative approach is to perform incomplete digestion during the digestion of previous organoids to retain smaller cell clumps and reduce the difficulty of self-assembly. However, this approach is accompanied by significant uncertainty and uncontrollability. Different organoids in the same culture system may also show significant differences in their sensitivity to digestion solutions. On the other hand, cells scattered in the gel environment cannot replicate the cell density of real tissues, which reduces the model's ability to reproduce actual tissue membrane surface contact, paracrine communication behaviors, and physiological environments such as hypoxia.
[0043] The method for preparing organoid microspheres provided by this invention is a simple method for constructing ultra-high cell density 3D cell / organoid models. This method is compatible with conventional manual plate making, as well as various mainstream and high-throughput 3D model construction technologies such as 3D bioprinting and droplet microfluidic microsphere preparation. It can maximize the reproduction of the cell density characteristics of real tissues and can be widely used in the fields of high-throughput organoid culture or high-throughput drug screening.
[0044] According to an embodiment of a second aspect of the present invention, a bio-ink for preparing organoid microspheres is provided, comprising: Cells with a hydrogel precursor enrichment layer on their surface, the hydrogel precursor enrichment layer being formed by the enrichment of hydrogel precursor material on the surface of the cells; And a low-viscosity resuspension in which the cells with a hydrogel precursor enrichment layer on their surface are dispersed.
[0045] The aforementioned bio-ink, as an intermediate product, is unique in that it combines a microscopic "core-shell" structure (with the cell as the core and the enrichment layer as the shell) with macroscopic low-viscosity fluid behavior. This structural design allows the bio-ink to maintain a stable dispersion during storage and transportation. When in use, it can be transformed into high-density three-dimensional gel microspheres with only simple cross-linking triggering, solving the industry problems of easy sedimentation, difficult handling, and short shelf life of traditional high-concentration cell / gel mixtures.
[0046] In some embodiments of the present invention, the concentration of the hydrogel precursor material in the low-viscosity resuspension is below the threshold for forming a macroscopic gel network.
[0047] In some embodiments of the present invention, the bio-ink includes at least one of the following: (b1) The cell density in the bio-ink is ≥5×10⁻⁶ 7 cells / mL; (b2) The cell density in the bio-ink is 5 × 10⁻⁶. 8 Cells / mL ~5×10 9 cells / mL; (b3) The hydrogel precursor material includes at least one of matrix gel, type I collagen, fibrin, methacrylamide collagen, methacrylamide gelatin, methacrylamide hyaluronic acid, or methacrylamide chitosan; (b4) The hydrogel precursor material interacts with the surface of the cell through electrostatic adsorption, hydrogen bonding or specific molecular binding to form the hydrogel precursor enrichment layer; (b5) The low-viscosity resuspension includes at least one of a buffer solution or a cell culture medium; (b6) The low-viscosity resuspension also contains a cross-linking trigger, which includes at least one of a photoinitiator, thrombin, or calcium ions.
[0048] In some embodiments of the present invention, the cell density in the bio-ink is ≥5×10⁻⁶. 7 Cells / mL. The cell density limit set by this invention breaks through the physical limits of traditional gel culture, enabling the intercellular spacing inside the constructed microspheres to reach the level of real tissue, which is conducive to the establishment of direct intercellular communication.
[0049] In some embodiments of the present invention, the cell density in the bio-ink is 5 × 10⁻⁶. 8 Cells / mL ~5×10 9 Cells / mL. For example, it could be 5 × 10⁻⁶. 8 cells / mL, 1×10 9 cells / mL, 2×10 9 cells / mL, 3×109 cells / mL, 4×10 9 cells / mL, 5×10 9 Cells / mL, or within the range of any two of the above values. This invention utilizes ultra-high cell density (5 × 10⁻⁶ cells / mL). 8 Cells / mL ~5×10 9 The cell / organoid culture system (5 × 10⁻⁶ cells / mL) is used to reproduce cell / organoid communication behaviors such as membrane surface contact and paracrine secretion, as well as physiological environments such as hypoxia. This invention defines an ultra-high cell density range (5 × 10⁻⁶ cells / mL). 8 Cells / mL ~5×10 9 The density of cells per mL is its core indicator that distinguishes it from other schemes. At this density, the cell sedimentation effect is greatly suppressed, and hypoxia gradients and paracrine factor enrichment areas can be spontaneously formed inside the microspheres, which highly simulates the pathophysiological characteristics of tissues such as solid tumors.
[0050] In some embodiments of the present invention, the hydrogel precursor material has cell surface affinity. The present invention uses a hydrogel precursor material with strong interaction with cells to incubate cells / organoids, forming a material-rich layer on the cell surface.
[0051] In some embodiments of the present invention, the hydrogel precursor material interacts with the surface of the cell through electrostatic adsorption, hydrogen bonding or specific molecular binding to form the hydrogel precursor enrichment layer.
[0052] Specifically, the specific molecular binding includes specific donor-acceptor binding, but is not limited to this; it is acceptable as long as there is a specific group that can specifically bind.
[0053] This invention utilizes the specific or non-specific interactions between the material and the cell surface to ensure that the hydrogel precursor material can be stably and uniformly anchored on the cell surface, preventing it from falling off during subsequent resuspension and washing in low-viscosity solutions. This ensures that each cell unit has independent gelation potential, laying the material basis for the subsequent construction of uniform high-density microspheres.
[0054] In some embodiments of the present invention, the hydrogel precursor material includes at least one of natural polymer materials, modified natural polymer materials, or synthetic polymer materials, but is not limited thereto.
[0055] In some embodiments of the present invention, the hydrogel precursor material includes at least one of Matrigel, Type I collagen, fibrin, methacrylamide collagen (ColMA), methacrylamide gelatin (GelMA), methacrylamide hyaluronic acid (HAMA), or methacrylamide chitosan (CSMA), but is not limited thereto.
[0056] This invention provides a variety of validated biocompatible material options, using hydrogel precursor materials that have strong interactions with cell surfaces (such as matrix gel, type I collagen, fibrin, methacrylamide collagen ColMA, methacrylamide gelatin GelMA, methacrylamide hyaluronic acid HAMA, methacrylamide chitosan CSMA, etc.). The selected materials are all major components of the extracellular matrix or their photosensitive modified derivatives, and can provide suitable cell adhesion and proliferation signals.
[0057] In some embodiments of the present invention, the low-viscosity resuspension includes at least one of a buffer solution or a cell culture medium, but is not limited thereto.
[0058] This invention uses incubated cells / organoids to be resuspended in a very small amount of solution of anhydrous gel precursor material. The subsequent culture model is constructed through cross-linking between the enrichment layer materials. Resuspending cells in a low-viscosity solution of the anhydrous gel precursor material avoids the difficulties in cell dispersion and uneven material distribution at ultra-high cell densities encountered in traditional methods, significantly increasing the maximum achievable cell density (≥5×10⁻⁶). 8 (cells / mL). This invention clarifies the key parameter boundaries for achieving high-throughput, high-density preparation, and uses buffer / culture medium containing little or no gel precursor as the resuspension medium, ensuring that the system maintains Newtonian or near-Newtonian fluid behavior even at extremely high cell loads.
[0059] In some embodiments of the present invention, the low-viscosity resuspension further comprises a crosslinking trigger, which is used to trigger a crosslinking reaction in the hydrogel precursor enrichment layer. The present invention integrates the "pre-mixed and used" and "instant crosslinking" processes by pre-mixing the crosslinking trigger in the low-viscosity resuspension, avoiding the disturbance to the stability of the high-density cell suspension caused by additional addition steps.
[0060] In some embodiments of the present invention, the crosslinking trigger includes at least one of a photoinitiator, thrombin, or calcium ions, but is not limited thereto. In the present invention, if the gelation transition process of the gel system requires the cooperation of other substances (e.g., photoinitiator for photocrosslinked hydrogels, thrombin and calcium ions for fibrin gels), the corresponding substances are added to a low-viscosity resuspension (e.g., PBS buffer) to prepare a commonly used concentration of cell resuspension solution; if not, the low-viscosity resuspension solution (e.g., PBS buffer) is used directly as the cell resuspension solution.
[0061] Ultimately, this invention defines the key specifications for commercially viable or ready-to-use bio-inks. The pre-contained crosslinking trigger formulation simplifies the end-user experience and reduces the risk of human error; the broad and extremely high cell density range covers diverse needs from basic research to clinical applications, ensuring the product's versatility and effectiveness across various downstream applications.
[0062] The present invention has at least the following beneficial effects: The organoid microsphere preparation method provided by this invention, through the innovative construction of a composite system of "cell surface hydrogel precursor enrichment layer + low viscosity resuspension," successfully breaks the inherent limitation of the positive correlation between cell density and system viscosity in traditional bio-ink preparation. Its core principle lies in confining the gelation reaction to the micrometer-scale of the cell surface, rather than occurring throughout the entire macroscopic system, thereby maintaining an ultra-high cell density (≥5×10⁻⁶). 8 While achieving a density of microspheres per mL, this method also endows the system with excellent low-viscosity rheological properties. This breakthrough has brought about several significant technological advancements: 1) It greatly improves the compatibility of high-throughput manufacturing, enabling 3D bioprinting speeds of over a thousand microspheres per minute without the risk of nozzle clogging; 2) It eliminates the problems of cell sedimentation and uneven distribution at high densities, ensuring batch-to-batch consistency; 3) Ultra-high cell density microspheres can more accurately reproduce key physiological microenvironments of real tissues, such as intercellular contact, paracrine signal transduction, and hypoxia gradients, significantly improving the predictive accuracy of organoid models in drug screening and disease research; 4) This method is compatible with various mainstream hydrogel materials and molding equipment, possessing broad applicability and industrialization prospects.
[0063] Unless otherwise specified, the term "about" in this invention actually means that the allowable error is within ±2%, for example, about 100 is actually 100 ± 2 × 100%.
[0064] Unless otherwise specified, "between" in this invention includes the number itself, for example, "between 2 and 3" includes the endpoint values 2 and 3.
[0065] Other features and advantages of the invention will be set forth in the description which follows, and will be apparent in part from the description, or may be learned by practicing the invention. Attached Figure Description
[0066] The above and / or additional aspects and advantages of the present invention will become apparent and readily understood from the description of the embodiments taken in conjunction with the following drawings, in which: Figure 1 This is a schematic diagram of the structure of one type of microfluidic chip in an embodiment of the present invention; Figure 2 This is a schematic diagram of the staining results of the ultra-high cell density organoid microspheres prepared based on droplet microfluidic technology on day 0 of culture using the Calcein-AM / PI live and dead cell staining kit in Example 1 of the present invention. Figure 3 This is a schematic diagram of the staining results of the ultra-high cell density organoid microrods prepared based on droplet microfluidic technology on day 0 of culture using the Calcein-AM / PI live and dead cell staining kit in Example 9 of the present invention. Figure 4 This is a schematic diagram of the staining results of the ultra-high cell density organoid microspheres prepared based on droplet microfluidic technology on the second day of culture using the Calcein-AM / PI live and dead cell staining kit in Example 7 of the present invention. Figure 5 This is a schematic diagram of the staining results of the ultra-high cell density organoid microspheres prepared based on droplet microfluidic technology on day 4 of culture using the Calcein-AM / PI live and dead cell staining kit in Example 7 of the present invention. Figure 6 This refers to the ultra-high cell density (5×10⁻⁶) prepared by 3D printing in Example 10 of this invention. 8 A schematic diagram comparing the construction effects of organoid microspheres (number per mL) and 3D-printed microspheres using the traditional method in Comparative Example 1; Figure 7 This refers to the ultra-high cell density (5×10⁻⁶) prepared by manual dispensing in Example 11 of this invention. 8 A schematic diagram comparing the construction effects of organoid microspheres (number per mL) with those of hand-dispensed microspheres using the traditional method in Comparative Example 2. Detailed Implementation
[0067] The following will describe the concept and technical effects of the present invention clearly and completely with reference to embodiments, so as to fully understand the purpose, features and effects of the present invention. Obviously, the described embodiments are only some embodiments of the present invention, not all embodiments. Other embodiments obtained by those skilled in the art based on the embodiments of the present invention without creative effort are all within the scope of protection of the present invention.
[0068] In the description of this invention, the terms "one embodiment," "some embodiments," "illustrative embodiment," "example," "specific example," or "some examples," etc., refer to specific features, structures, materials, or characteristics described in connection with that embodiment or example, which are included in at least one embodiment or example of the invention. In this specification, the illustrative expressions of the above terms do not necessarily refer to the same embodiment or example. Furthermore, the specific features, structures, materials, or characteristics described may be combined in any suitable manner in one or more embodiments or examples.
[0069] Unless otherwise specified, the temperature in the specific implementation method is room temperature, that is, within the range of 20~30℃, and fluctuations within this range will not have a significant impact on the test results.
[0070] If the experimental method does not specify the specific conditions in the detailed implementation, it is generally performed according to the conventional conditions in the art or the conditions recommended by the manufacturer.
[0071] Unless otherwise specified, all raw materials and reagents used are available from commercial channels such as the regular market.
[0072] Example 1 (1) Prepare a 4% (w / v) gel precursor solution of the hydrogel precursor material methacryloyl hyaluronic acid (HAMA); (3) Digest HT-29 cells into single-cell state and count the cells; (4) Resuspend the digested single cells in the gel precursor solution to a cell density of 0.5 × 10⁻⁶. 8 Cells / mL, incubate the cell suspension at room temperature or 37°C for 15 minutes with static or slow shaking, and remove the supernatant by centrifugation; (5) Based on a cell density of 5×10 8 By adding a certain amount of the corresponding cell resuspension solution (PBS buffer containing 0.25% (w / v) LAP) to the cell pellet, ultra-high cell density bio-ink can be obtained and used for organoid microsphere construction; (6) Load the ultra-high cell density bio-ink into the syringe and connect it to the syringe. Figure 1 The aqueous inlet of the microfluidic chip is shown, and HFE-7200 electronic fluorinated liquid is simultaneously introduced into the oil inlet. This causes the ultra-high cell density bio-ink to be sheared into microdroplets by the fluorinated liquid in the microfluidic chip, and then formed into microspheres in the middle section of the outlet pipe under 405 nm light. (7) Introduce the microspheres suspended in the fluorinated solution into the target culture vessel, remove the excess fluorinated solution and let it stand for 30 seconds. After the remaining small amount of fluorinated solution has completely evaporated, add the corresponding culture medium to the culture vessel and place it in a cell culture incubator for normal culture to obtain organoid microspheres.
[0073] Example 2 The difference from Example 1 is that in this example, the hydrogel precursor material is methacrylamide gelatin (GelMA). Its affinity mechanism differs from that of Example 1. The GelMA molecular chain contains an arginine-glycine-aspartic acid (RGD) sequence, which integrin receptors on the cell surface can specifically recognize and bind to, ensuring the stability of the enrichment layer.
[0074] The rest is the same as in Example 1, and will not be repeated here.
[0075] Example 3 The difference from Example 1 is that: in this example, the hydrogel precursor material is fibrin, which has a different cross-linking method than that in Example 1. At the same time, thrombin (5 U / mL) and calcium ions (20 mmol / L) are added to the low viscosity resuspension PBS to trigger enzymatic cross-linking.
[0076] The rest is the same as in Example 1, and will not be repeated here.
[0077] Example 4 The difference from Example 1 is that in this example, the hydrogel precursor material HAMA is prepared as a 2% (w / v) gel precursor solution.
[0078] The rest is the same as in Example 1, and will not be repeated here.
[0079] Example 5 The difference from Example 1 is that in this example, the hydrogel precursor material HAMA is prepared as a 10% (w / v) gel precursor solution.
[0080] The rest is the same as in Example 1, and will not be repeated here.
[0081] Example 6 The difference from Example 1 is that in this example, the cell density in the bio-ink is 5 × 10⁻⁶. 9 per mL.
[0082] The rest is the same as in Example 1, and will not be repeated here.
[0083] Example 7 The difference from Example 1 is that in this example, the cell density in the bio-ink is 7 × 10⁻⁶. 8 per mL.
[0084] The rest is the same as in Example 1, and will not be repeated here.
[0085] Example 8 The difference from Example 1 is that the cells used in this example are different; this example uses SW480 cells.
[0086] The rest is the same as in Example 1, and will not be repeated here.
[0087] Example 9 The difference from Example 1 is that in this example, the following is used: Figure 1 The microfluidic chip shown cuts ultra-high cell density bio-ink into short rod-shaped microspheres (i.e., microrods), which are then used to obtain organoid microrods.
[0088] The rest is the same as in Example 1, and will not be repeated here.
[0089] Example 10 The difference from Example 1 is that in this example, microspheres are formed using 3D bioprinting. The specific steps are as follows: ultra-high cell density bio-ink is loaded into the bio-ink cartridge of the 3D bioprinter, connected to the printer, and then the microsphere dot matrix printing function of the printer is used to extrude the bio-ink at a microsphere volume of 1 μL / microsphere into a cell culture plate. The microspheres are solidified by 405nm light irradiation, and the appropriate culture medium is added to the culture environment. The plate is then placed in a cell culture incubator for normal culture.
[0090] The rest is the same as in Example 1, and will not be repeated here.
[0091] Example 11 The difference from Example 1 is that in this example, bio-ink is applied to the well plate manually to form droplets, which are then used to obtain organoid droplets. The specific steps of manual dispensing are as follows: using a pipette to draw up ultra-high cell density bio-ink, the bio-ink is extruded into the cell culture plate at a volume of 5 μL / microsphere, the microspheres are solidified by irradiation with 405 nm light, the appropriate culture medium is added to the culture environment, and the plate is placed in a cell culture incubator for normal culture.
[0092] The rest is the same as in Example 1, and will not be repeated here.
[0093] Comparative Example 1 The difference from Example 10 is that: this comparative example uses a conventional high-concentration gel mixing system and the same high cell density as in Example 10, but uses a conventional method to directly mix the cells in a high-concentration hydrogel system (10% GelMA solution) to form bio-ink, which is then used for 3D bioprinting.
[0094] The rest is the same as in Example 10, and will not be repeated here.
[0095] Comparative Example 2 The difference from Example 11 is that: this comparative example uses a conventional high-concentration gel mixing system and the same high cell density as in Example 11, but uses a conventional method to directly mix the cells in the high-concentration hydrogel system (10% GelMA solution) to form bio-ink, and then performs manual dispensing.
[0096] The rest is the same as in Example 11, and will not be repeated here.
[0097] Test case Cells within the microspheres obtained in the examples and comparative examples were stained using the Calcein-AM / PI live / dead cell staining kit at the target time point to analyze cell viability.
[0098] The construction effects of ultra-high cell density cell / organoid culture systems in different embodiments and comparative examples are shown in the figures. In the figures, green represents live cells and red represents dead cells.
[0099] Figure 2 The staining results of the ultra-high cell density organoid microspheres prepared based on droplet microfluidic technology in Example 1 of this invention on day 0 of culture using the Calcein-AM / PI live / dead cell staining kit show that the microspheres have intact structure and good cell activity.
[0100] Figure 3 The staining results of the ultra-high cell density organoid microrods prepared based on droplet microfluidic technology in Example 9 of this invention on day 0 of culture using the Calcein-AM / PI live / dead cell staining kit show that the microrods have intact structures and good cell viability.
[0101] Figure 4 , Figure 5 These are the staining results of the ultra-high cell density organoid microspheres prepared based on droplet microfluidic technology in Example 7 of this invention on day 2 and day 4 of culture using the Calcein-AM / PI live / dead cell staining kit, with a cell density of 7 × 10⁻⁶. 8 Cells / mL. As shown in the figure, with the increase of culture time, the cells showed obvious proliferation, with an increase in both live and dead cells; live cells proliferated normally, and their smaller intercellular spaces based on the ultra-high cell density model further aggregated and expanded; dead cells were mainly concentrated inside the ultra-high cell density model, and hypoxic necrosis areas began to appear in the center of the microspheres, mainly due to hypoxia and lack of nutrients, which is somewhat similar to hypoxic necrosis in the center of real tumors in vivo.
[0102] Figure 6 This refers to the ultra-high cell density (5×10⁻⁶) prepared by 3D printing in Example 10 of this invention. 8A schematic diagram comparing the 3D printing microspheres (cells / mL) of organoid microspheres with those of the conventional method in Comparative Example 1. The figure shows the staining results of the Calcein-AM / PI live / dead cell staining kit on day 0 of culture; green: live cells; red: dead cells. Comparing the 3D bioprinting microsphere construction effects of the method of the present invention and the conventional method at ultra-high cell density, with the same total number of cells and ink volume, the microspheres prepared by the method of the present invention have fewer free cells, a larger microsphere diameter, and more regular and tightly arranged cell boundaries. In addition, Comparative Example 1 encountered problems such as excessive macroscopic viscosity, nozzle clogging, uneven cell sedimentation, and irregular microsphere shape during printing. The microspheres obtained in Example 10 of the present invention have significant advantages in morphological uniformity, cell distribution uniformity, and printing throughput, indicating that the method of the present invention has a significantly better microsphere construction effect than the conventional method at ultra-high cell density, confirming the "low viscosity resuspension" and "surface enrichment" effects of the present invention.
[0103] Figure 7 This refers to the ultra-high cell density (5×10⁻⁶) prepared by manual dispensing in Example 11 of this invention. 8 A schematic diagram comparing the construction effects of organoid microspheres (number / mL) and hand-dispensed microspheres using the traditional method in Comparative Example 2. The figure shows the staining results of the Calcein-AM / PI live / dead cell staining kit on day 1 (top row) and day 3 (bottom row) of culture; green: live cells; red: dead cells. Comparing the hand-dispensed droplet construction effects of the method of this invention and the traditional method under ultra-high cell density, with the same total cell count and ink volume, the droplets prepared by the method of this invention have better cell culture effects. On day 3 of culture, the cell activity of the droplets prepared by the method of this invention is much higher than that prepared by the traditional method, and the droplets prepared by the method of this invention reproduce the approximate characteristics of hypoxic necrosis with gradual apoptosis in the central region.
[0104] The embodiments of the present invention have been described in detail above with reference to the accompanying drawings. However, the present invention is not limited to the above embodiments, and various changes can be made within the scope of knowledge possessed by those skilled in the art without departing from the spirit of the present invention. Furthermore, the embodiments of the present invention and the features thereof can be combined with each other unless otherwise specified.
Claims
1. A method for preparing organoid microspheres, characterized in that, Including the following steps: Cells are incubated using hydrogel precursor materials to form a hydrogel precursor enrichment layer on the surface of the cells; Cells with the hydrogel precursor enrichment layer on their surface were resuspended using a low-viscosity resuspension solution to obtain bio-ink; The bio-ink is shaped into microspheres, and a cross-linking reaction is triggered in the hydrogel precursor enrichment layer to obtain the organoid microspheres.
2. The preparation method according to claim 1, characterized in that, The hydrogel precursor material has cell surface affinity; And / or, the hydrogel precursor material includes at least one of natural polymer materials, modified natural polymer materials, or synthetic polymer materials; And / or, the hydrogel precursor material interacts with the surface of the cell through electrostatic adsorption, hydrogen bonding, or specific molecular binding to form the hydrogel precursor enrichment layer.
3. The preparation method according to claim 2, characterized in that, The hydrogel precursor material includes at least one of matrix gel, type I collagen, fibrin, methacrylamide collagen, methacrylamide gelatin, methacrylamide hyaluronic acid, or methacrylamide chitosan.
4. The preparation method according to claim 1, characterized in that, The cell density in the bio-ink is ≥5×10⁻⁶ 7 Cells / mL, preferably 5×10 8 Cells / mL ~5×10 9 per mL.
5. The preparation method according to claim 1, characterized in that, Includes at least one of the following: (a1) Prepare a precursor solution of the hydrogel precursor material with a mass-volume concentration of 0.5% to 50%, and incubate the cells with it; (a2) The incubation time is 2 to 30 minutes; (a3) The low-viscosity resuspension includes at least one of a buffer solution or a cell culture medium; (a4) The low-viscosity resuspension also contains a cross-linking triggering agent, which is used to trigger the cross-linking reaction of the hydrogel precursor enrichment layer; (a5) The low-viscosity resuspension also contains a cross-linking trigger, which includes at least one of a photoinitiator, thrombin, or calcium ions; (a6) The cells are in a single-cell state or incompletely digested cell clumps; (a7) The source of the cells includes patient-derived tumor organoids, tumor cell lines or primary cells.
6. The preparation method according to claim 1, characterized in that, The bio-ink is formed into microspheres using 3D bioprinting, droplet microfluidics, or manual dotting.
7. The preparation method according to claim 5, characterized in that, Triggering the crosslinking reaction of the hydrogel precursor enrichment layer includes at least one of the following methods: When the hydrogel precursor material is a photosensitive material, the microspheres are irradiated with a light source of a specific wavelength to induce photopolymerization and crosslinking. When the hydrogel precursor material is fibrin, enzymatic cross-linking is triggered by thrombin and calcium ions contained in the low-viscosity resuspension. When the hydrogel precursor material is an ion-sensitive material, the microspheres are introduced into a crosslinking bath containing divalent cations for ion crosslinking.
8. The application of a method for preparing organoid microspheres as described in any one of claims 1-7 in the fields of high-throughput organoid culture or high-throughput drug screening.
9. A bio-ink for preparing organoid microspheres, characterized in that, include: Cells with a hydrogel precursor enrichment layer on their surface, the hydrogel precursor enrichment layer being formed by the enrichment of hydrogel precursor material on the surface of the cells; And a low-viscosity resuspension in which the cells with a hydrogel precursor enrichment layer on their surface are dispersed.
10. The bio-ink according to claim 9, characterized in that, Includes at least one of the following: (b1) The cell density in the bio-ink is ≥5×10⁻⁶ 7 cells / mL; (b2) The cell density in the bio-ink is 5 × 10⁻⁶. 8 Cells / mL ~5×10 9 cells / mL; (b3) The hydrogel precursor material includes at least one of matrix gel, type I collagen, fibrin, methacrylamide collagen, methacrylamide gelatin, methacrylamide hyaluronic acid, or methacrylamide chitosan; (b4) The hydrogel precursor material interacts with the surface of the cell through electrostatic adsorption, hydrogen bonding or specific molecular binding to form the hydrogel precursor enrichment layer; (b5) The low-viscosity resuspension includes at least one of a buffer solution or a cell culture medium; (b6) The low-viscosity resuspension also contains a crosslinking trigger, which includes at least one of a photoinitiator, thrombin, or calcium ions.
